A 49-year-old man with contractures, weakness, and cardiac arrhythmia

Neurology

Volumn 72, Issue 23, 2009, Pages 2036-2043

  Kissel, J T ^a   Dimberg, E L ^b   Emslie Smith, A M ^b   Selcen, D ^b   Keegan, B M ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVERSION; CONTRACTURE; ELBOW; ELECTROMYOGRAPHY; EMERY DREIFUSS DYSTROPHY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; HEART ARRHYTHMIA; HEART ATRIUM FLUTTER; HUMAN; INCLUSION BODY MYOSITIS; MUSCLE ATROPHY; MYOPATHY; NOTE; PRIORITY JOURNAL; WEAKNESS; X CHROMOSOME LINKED DISORDER;

EID: 67649467453     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000350522.42635.09     Document Type: Article

References (35)

1. Doyle AC. The Adventure of the Beryl Coronet. In: The Complete Sherlock Holmes. Garden City: Garden City Publishing Co.; 1927:360.
2. Hilton-Jones D, Kissel JT. The examination and investigation of the patient with muscle disease. In: Karpati G, Hilton-Jones D, Griggs RC, eds. Disorders of Voluntary Muscle. Cambridge: Cambridge University Press; 2001: 349-373.
3. Norwood F, De Visser M, Eymard B, Lochmuller H, Bushby K. EFNS guideline on diagnosis and management of limb girdle muscular dystrophies. Eur J Neurol 2007; 14:1405-1412.
4. Pestronk A. Contractures with myopathy or other neuromuscular disease. Neuromuscular Home Page. Available at: http://neuromuscular.wustl.edu/msys/ contract.html. Accessed July 15, 2008.
5. Amato AA, Kagan-Hallet K, Jackson CE, et al. The wide spectrum of mofibrillar myopathy suggests a multifactorial etiology and pathogenesis. Neurology 1998;51:1646- 1655.
6. Selcen D, Ohno K, Engel AG. Myofibrillar myopathy: clinical, morphological, and genetic studies in 63 patients. Brain 2004;127:439-451.
7. Emery AE. Emery-Dreifuss muscular dystrophy: a 40-year retrospective. Neuromuscul Disord 2000;10:228-232.
8. Al-Jaberi MM, Katirji B. Serum muscle enzymes in neuromuscular disease. In: Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro BE. Neuromuscular Disorders in Clinical Practice. Boston: Butterworth Heinemann; 2002: 39-47.
9. Finsterer J, Stollberger C. Primary myopathies and the heart. Scand Cardiovasc J 2008;42:9-24.
10. Benedetti S, Menditto I, Degano M, et al. Phenotypic clustering of lamin A/C mutations in neuromuscular patients. Neurology 2007;69:1285-1292.
11. Worman HJ, Bonne G. "Laminopathies": a wide spectrum of human diseases. Exp Cell Res 2007;313:2121-2133.
12. Miller TM. Differential diagnosis of the myotonic disorders. Muscle Nerve 2008;37:293-299.
13. Logigian EL, Ciafaloni E, Quinn C, et al. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy. Muscle Nerve 2007;35:479-485.
14. Muller-Felber W, Horvath R, Gempel K, et al. Late onset Pompe disease: clinical and neurophysiological spectrum in 38 patients including long-term follow-up in 18 patients. Neuromuscul Disord 2007;17:698-706.
15. Winkel LPF, Hagemans MLC, van Doorn PA. Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. J Neurol 2005;252:875-884.
16. Selcen D, Engel AG. Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol 2005; 57:269-276.
17. Selcen D, Engel AG. Mutation in myotilin cause myofibrillar myopathy. Neurology 2004;6:1363-1371.
18. Vorgerd M, van der Ven PF, Bruchertseifer V, et al. A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. Am J Hum Genet 2005;77:297-304.
19. Selcen D, Engel AG. Myofibrillar myopathy caused by novel dominant negative alpha --crystallin mutations. Ann Neurol 2003;54:804-810.
20. Dreifuss FE, Hogan GR. Survival in X-chromosomal muscular dystrophy. Neurology 1961;11:734-737.
21. Emery AE, Dreifuss FE. Unusual type of benign X-linked muscular dystrophy. J Neurol Neurosurg Psychiatry 1966; 29:338-342.
22. Rowland LP, Fetell M, Olarte M, Hays A, Singh N, Wanat FE. Emery-Dreifuss muscular dystrophy. Ann Neurol 1979;5:111-117.
23. Emery AE. Emery-Dreifuss syndrome. J Med Genet 1989; 26:637-641.
24. Emery AE. Emery-Dreifuss muscular dystrophy and other related disorders. Br Med Bull 1989;45:772-787.
25. Marshall TM, Huckell VF. Atrial paralysis in a patient with Emery-Dreifuss muscular dystrophy. Pacing Clin Electrophysiol 1992;15:135-140.
26. Emery AE. Emery-Dreifuss muscular dystrophy: a 40-year retrospective. Neuromuscul Disord 2000;10:228-232.
27. Rudenskaya GE, Ginter EK, Petrin AN, Djomina NA. Emery-Dreifuss syndrome: Genetic and clinical varieties. Am J Med Genet 1994;50:228-233.
28. Ura S, Hayashi YK, Goto K, et al. Limb-girdle muscular dystrophy due to emerin gene mutations. Arch Neurol 2007;64:1038-1041.
29. Rowinska-Marcinska K, Szmidt-Salkowska E, Fidzianska A, et al. Atypical motor unit potentials in Emery-Dreifuss muscular dystrophy (EDMD). Clin Neurophysiol 2005;116:2520-2527.
30. Paradas C, Marquez C, Gallardo E, et al. X-linked Emery- Dreifuss muscular dystrophy and vacuoles: an immunohistochemical characterization. Muscle Nerve 2005;32: 61-65.
31. Bione S, Maestrini E, Rivella S, et al. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet 1994;8:323-327.
32. Sabatelli P, Squarzoni S, Petrini S, et al. Oral exfoliative cytology for the non-invasive diagnosis in X-linked Emery- Dreifuss muscular dystrophy patients and carriers. Neuromuscul Disord 1998;8:67-71.
33. Cartegni L, Raffaele di Barletta M, Barresi R, et al. Heartspecific localization of emerin: New insights into Emery- Dreifuss muscular dystrophy. Hum Mol Genet 1997;6: 2257-2264.
34. Holaska JM, Wilson KL. Multiple roles for emerin: implications for Emery-Dreifuss muscular dystrophy. Anat Rec A Discov Mol Cell Biol 2006;228A:676-680.
35. Doyle AC. The Adventure of the Empty House. In: The Complete Sherlock Holmes. Garden City: Garden City Publishing Co.; 1927:574.